TAVR Found Non-Inferior to SAVR for Low-Risk Patients
Trial bolsters evidence that less invasive strategy is safe and effective in younger, lower-risk patients
Stay updated with breaking news from Moritz Seiffert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Trial bolsters evidence that less invasive strategy is safe and effective in younger, lower-risk patients
Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated with substantial decreased rates of death or stroke at one year in low-risk patients, compared with surgical aortic valve replacement (SAVR), according to findings presented at the American College of Cardiology's Annual Scientific Session.
The investigator-initiated study was strengthened by operators being able to choose which device to implant.
(UPDATED) The investigator-initiated study was strengthened by operators being able to choose which device to implant.